116 related articles for article (PubMed ID: 7773483)
1. Predicting axillary node positivity in patients with invasive carcinoma of the breast by using a combination of T category and palpability.
Silverstein MJ; Gierson ED; Waisman JR; Colburn WJ; Gamagami P
J Am Coll Surg; 1995 Jun; 180(6):700-4. PubMed ID: 7773483
[TBL] [Abstract][Full Text] [Related]
2. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast.
Giuliano AE; Barth AM; Spivack B; Beitsch PD; Evans SW
J Am Coll Surg; 1996 Sep; 183(3):185-9. PubMed ID: 8784309
[TBL] [Abstract][Full Text] [Related]
5. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
6. Predictors of axillary lymph node metastasis in T1 breast carcinoma.
Shoup M; Malinzak L; Weisenberger J; Aranha GV
Am Surg; 1999 Aug; 65(8):748-52; discussion 752-3. PubMed ID: 10432085
[TBL] [Abstract][Full Text] [Related]
7. Results from a multidisciplinary breast center. Analysis of disease discovered.
Silverstein MJ; Gamagami P; Masetti R; Legmann MD; Craig PH; Gierson ED
Surg Oncol Clin N Am; 1997 Apr; 6(2):301-14. PubMed ID: 9115497
[TBL] [Abstract][Full Text] [Related]
8. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL; Collins L; Peiro G; Recht A; Come S; Shulman LN; Silver B; Nixon A; Harris JR; Schnitt SJ; Connolly JL
Cancer; 1998 Dec; 83(12):2502-8. PubMed ID: 9874455
[TBL] [Abstract][Full Text] [Related]
9. Axillary lymph node metastases in patients with small carcinomas of the breast: is accurate prediction possible?
Anan K; Mitsuyama S; Tamae K; Nishihara K; Iwashita T; Abe Y; Ihara T; Toyoshima S
Eur J Surg; 2000 Aug; 166(8):610-5. PubMed ID: 11003428
[TBL] [Abstract][Full Text] [Related]
10. Selective or routine axillary disease staging for patients with clinically lymph node-negative breast cancer?
Hieken TJ; Velasco JM
Surgery; 2006 Oct; 140(4):500-7; discussion 507-8. PubMed ID: 17011896
[TBL] [Abstract][Full Text] [Related]
11. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
12. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
13. Pathology and behavior of small breast carcinomas.
Meyer JS; Fahrner M; Daniel FC
Semin Diagn Pathol; 1999 Aug; 16(3):257-68. PubMed ID: 10490202
[TBL] [Abstract][Full Text] [Related]
14. Predicting axillary nodal positivity in 2282 patients with breast carcinoma.
Silverstein MJ; Skinner KA; Lomis TJ
World J Surg; 2001 Jun; 25(6):767-72. PubMed ID: 11376414
[TBL] [Abstract][Full Text] [Related]
15. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
16. Can sentinel lymph node biopsy be omitted in patients with favorable breast cancer histology?
Mendez JE; Fey JV; Cody H; Borgen PI; Sclafani LM
Ann Surg Oncol; 2005 Jan; 12(1):24-8. PubMed ID: 15827774
[TBL] [Abstract][Full Text] [Related]
17. Prediction of axillary lymph node involvement of women with invasive breast carcinoma: a multivariate analysis.
Olivotto IA; Jackson JS; Mates D; Andersen S; Davidson W; Bryce CJ; Ragaz J
Cancer; 1998 Sep; 83(5):948-55. PubMed ID: 9731899
[TBL] [Abstract][Full Text] [Related]
18. Breast carcinoma grading, estimation of tumor size, axillary lymph node status, staging, and nottingham prognostic index scoring on mastectomy specimens.
Ahmad Z; Khurshid A; Qureshi A; Idress R; Asghar N; Kayani N
Indian J Pathol Microbiol; 2009; 52(4):477-81. PubMed ID: 19805950
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node metastases associated with small invasive breast carcinomas.
Maibenco DC; Weiss LK; Pawlish KS; Severson RK
Cancer; 1999 Apr; 85(7):1530-6. PubMed ID: 10193943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
